期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

动态增强磁共振成像在评估氩氦冷冻术治疗前列腺癌疗效中的价值

Value of dynamic contrast-enhanced magnetic resonance imaging in evaluating the effect of argon-helium cryoablation on prostate cancer
原文传递
导出
摘要 氩氦冷冻（AHC）是治疗局部前列腺癌（PCa）的一种新的有效方法，可作为一线治疗手段，也可作为局部复发后的补救治疗。在欧美已成为PCa的常规疗法之一，而在我国尚处起步阶段。AHC治疗后的病灶仍然有肿瘤残留或复发的可能，需及时发现并进行补救性治疗，因而对术后疗效的准确评估十分重要。动态增强MRI（DCE—MRI）是功能性成像技术，其在PCa诊断中所具有的较高敏感性与特异性已被广泛认同Ⅲ。本研究旨在评价DCE—MRI在AHC治疗PCa后疗效评估中的价值。
作者 肖渤瀚 叶兆祥 赵颖如 王海涛
机构地区 天津医科大学肿瘤医院放射科天津市肿瘤防治重点实验室
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2016年第8期885-887,共3页 Chinese Journal of Geriatrics
关键词 前列腺肿瘤 磁共振成像 冷冻疗法 Prostatic neoplasms Magneticresonance imaging Cryotherapy
分类号 R737.25 [医药卫生—肿瘤] R445.2 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献7

  • 1Shah TT, Ahmed H, Kanthabalan A, et al. Focal cryotherapy of localized prostate cancer: a systematic review of the literature[J]. Expert Rev Anticancer Ther, 2014, 14( 11 ): 1337-1347.
  • 2Rouviere O. Imaging techniques for local recurrence of prostate cancer: for whom, why and how[J]? Diagn Interv Imaging, 2012, 93( 4 ) :279-290.
  • 3楼慧玲,陈巧聪.前列腺特异性抗原及骨标志物检测对前列腺癌骨转移患者诊断的意义[J].中华老年医学杂志,2012,31(5):421-424. 被引量：21
  • 4Kier R, Wain S, Troiano R. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma[J]. AJR Am J Roentgenol, 1993, 161 (3) : 601-606.
  • 5Kalbhen CL, Hricak H, Shinohara K, et al. Prostate carcinoma: MR imaging findings after cryosurgery[J]. Radiology, 1996, 198( 3 ): 807-811.
  • 6Rouviere O, Raudrant A, Ecochard R, et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MRI [J]. Eur Radiol, 2003, 13( 5 ): 931- 942.
  • 7HaraN, Okuizumi M, Koike H, et al. Dynamic contrast enhanced magnetic resonance imaging(DCE- MRI)is a useful modality for the precise detection and staging of early prostate cancer [J]. Prostate, 2005, 62( 2 ): 140 147.

二级参考文献12

  • 1朱生才,刘明,王建业.血清前列腺特异抗原4～10μg/L的前列腺癌“灰区”的诊断和治疗[J].中华老年医学杂志,2006,25(4):269-271. 被引量：10
  • 2Ramankulov A, Lein M, Kristiansen G, et al. Plasma osteopontin in comparison with bone markers as indicator o{ bone metastasis and survival outcome in patients with prostate cancer. Prostate, 2007, 67:330-340.
  • 3Lein M, Miller K, Wirth M, et al. Bone turnover markers as predictive tools {or skeletal complications in men with metastatic prostate cancer treated with zoledronic acid. Prostate, 2009, 69: 624-632.
  • 4Zhang L, Ji G, Li X, et al. fPSA/tPSA ratio optimize the early diagnosis is in the prostate cancer. Chin J Androl, 2004, 10: 582-585.
  • 5Thompson KE,Hernandez J, CanbFHagino ED, et al. Prognostic features in men who died of prostate cancer. J Urol, 2005, 174: 553-556.
  • 6Zafeirakis AG,Papatheodorou GA, Limouris GS, et: al. Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases. Nuclear Medicine Communications, 2010, 31: 249-253.
  • 7Jung K, Lein M, Stephan C,et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer, 2004, 111: 788-791.
  • 8Korpela J,Tiitinen SL, Hiekkanen H, et al. Serum TRACP 5b and ICTP as marker of bone metastases in breast cancer. Anticancer Res, 2006, 26 : 3127-3132.
  • 9Koopmans N, De Jong IJ, Breeuwsma AJ, et al. Serum bone turnover markers (PINP and ICTP) for Lhe early detection of bone metastases in patients with prostate cancer: a longitudinal approach. Urol, 2007, 178:849-853.
  • 10Ozu C,Nakashima J, Horiguchi Y, et al. Prediction of bone metastases by combination o{ tartrate- resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. International Journal of Urology, 2008, 15, 419-422.

共引文献20

中华老年医学杂志
2016年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部